Adherence and Efficacy of Screening for Low Bone Mineral Density Among Ulcerative Colitis Patients Treated With Corticosteroids

作者：Khan Nabeel; Abbas Ali M; Almukhtar Rawaa M; Cole Elisabeth B; Khan Amna N

来源：American Journal of Gastroenterology, 2014, 109(4): 572-578.

DOI：10.1038/ajg.2013.486

OBJECTIVES: Ulcerative colitis (UC) is associated with an increased risk of metabolic bone disease and fragility fractures. The aim of this study was to assess the adherence to the guidelines issued by the American Gastroenterology Association (AGA) for the screening for low bone density in UC patients and to assess the benefits of dual-energy X-ray absorptiometry (DXA) screening among corticosteroid (CS)-treated UC patients. %26lt;br%26gt;METHODS: Nationwide Veterans Affairs system (VA) data were obtained. UC patients followed up in the VA between 2001 and 2011 and the occurrence of fragility fractures were identified using International Classification of Diseases, Ninth Revision codes. Exposure to CSs was assessed using pharmacy data. DXA screening was assessed using the VA procedure database. Post DXA screening, medication use was also assessed from the pharmacy database. Cox regression analysis was performed to calculate the hazard ratio (HR) of fragility fractures among those patients who received DXA compared with those who did not. %26lt;br%26gt;RESULTS: We included 5,736 patients. Among them, 80 (1.4 %) patients suffered from fragility fractures during the follow-up period. Overall adherence rate to AGA guidelines was 23 %. Adherence rate was highest among postmenopausal women (48 %) and lowest among men above 50 years of age (20 %). UC patients who received DXA screening were more likely to be started on bisfosfonates (P %26lt; 0.001), calcitonin (P %26lt; 0.001), vitamin D, and calcium (P %26lt; 0.001) compared with those who did not receive screening. Those who received DXA screening were half as likely (HR = 0.5, 0.3 -0.9, P = 0.03) to develop fragility fractures as compared with those who did not receive screening. The benefi ts were more prominent among those with higher CS exposure. %26lt;br%26gt;CONCLUSIONS: Rates of DXA screening were low among CS-treated UC patients. Those who received DXA screening were more likely to be started on antiresorptive therapy and supplemental medications and had a 50 % reduction in the risk of fragility fractures. More efforts should be directed toward raising the adherence to AGA guidelines and the awareness of DXA benefits.

• 出版日期2014-4